← Back to Search

Smell training for Loss of Smell (OTTODC19 Trial)

N/A
Recruiting
Led By Johannes A Frasnelli, PhD
Research Sponsored by Université du Québec à Trois-Rivières
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measurement will be taken at time zero (pre-intervention)
Awards & highlights

OTTODC19 Trial Summary

This trial will help assess if olfactory training can help improve olfactory function in patients with post-COVID olfactory dysfunction.

Eligible Conditions
  • Loss of Smell
  • COVID-19
  • Parosmia
  • Reduced Sense of Smell
  • Coronavirus

OTTODC19 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measurement will be taken at time zero (pre-intervention) and 12 weeks (post-intervention)
This trial's timeline: 3 weeks for screening, Varies for treatment, and measurement will be taken at time zero (pre-intervention) and 12 weeks (post-intervention) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes from baseline in olfactory score on the Sniffin's Sticks test
Changes from baseline in olfactory score on the University of Pennsylvania Identification Test (UPSIT) [ Time Frame: Measurement will be taken at time zero (pre-intervention) and 12 weeks (post-intervention)
Parosmia and phantosmia assessment test
+2 more
Secondary outcome measures
Nasal Obstruction Symptom Evaluation (NOSE)

OTTODC19 Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: Chemosensory training group 2Experimental Treatment1 Intervention
For 12 weeks, morning and evening, smell four odors namely coffee aroma, cheese aroma, strawberries, and limon, for a total of five minutes per session.
Group II: Chemosensory training group 1Experimental Treatment1 Intervention
For 12 weeks, morning and evening, smell four odors namely eucalyptol, phenyl ethanol, Orange, and eugenol, for a total of five minutes per session.
Group III: Chemosensory training group 3Placebo Group1 Intervention
For 12 weeks, morning and evening, smell four same odorless substance.

Find a Location

Who is running the clinical trial?

Université du Québec à Trois-RivièresLead Sponsor
42 Previous Clinical Trials
4,278 Total Patients Enrolled
Johannes A Frasnelli, PhDPrincipal InvestigatorUniversité du Québec à Trois-Rivières

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the maximum capacity of participants in this trial?

"Indeed, clinicaltrials.gov reports that this research trial has been actively enlisting participants since May 1st 2022. The most recent update occurred on the 20th of May and 105 individuals are required for the study to be conducted at one medical facility."

Answered by AI

Is enrollment for this research project open at present?

"Affirmative. According to the clinicaltrials.gov website, recruitment for this trial is still underway after it was initially posted on May 1st 2022 and last updated 20th of May the same year. The study aims to enrol 105 patients from a single site."

Answered by AI

Who else is applying?

What state do they live in?
New Mexico
South Carolina
Texas
How old are they?
65+
18 - 65
What site did they apply to?
Université du Québec à Trois-Rivières
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
How many prior treatments have patients received?
1

What questions have other patients asked about this trial?

Pourrais-je participer si j'habite aux Etats-Unis?
PatientReceived no prior treatments

Why did patients apply to this trial?

J'ai perdu mon odorat quand j'ai eu COVID en mai. Je suis une coeliac et j'avais l'odorat formidable avant Covid. Les steroides l'ont ameliore, mais apres l'anosmie est revenue. Quelque fois je sens un peu, autres, rien. L'acupuncture m'aidait mais c'est cher d'y aller beaucoup. Je veux le retour de mon odorat.
PatientReceived no prior treatments
Recent research and studies
clinicaltrials.govStudy
Olfactory Training as a Treatment for Olfactory Dysfunction Post COVID-19
2022. "Olfactory Training as a Treatment for Olfactory Dysfunction Post COVID-19". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05384561.
~36 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top